Cancer Research Cancer Research Funding Available  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 3066-3071, June 1, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stahl, A.
Right arrow Articles by Mueller, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stahl, A.
Right arrow Articles by Mueller, B. M.

Binding of Urokinase to Its Receptor Promotes Migration and Invasion of Human Melanoma Cells in Vitro1

Andreas Stahl2 and Barbara M. Mueller3

Department of Immunology, The Scripps Research Institute, La Jolla, California 92037

Previously, we reported that urokinase-type plasminogen activator (uPA) plays a pivotal role in extracellular matrix dissolution by malignant melanoma cells. Here, we demonstrate that a highly metastatic melanoma cell line (M24met) that secretes uPA expresses high levels of the uPA receptor (uPAR), 2.4 x 106 binding sites/cell with a KD of 5.67 x 10-10 M. The receptor was identified as a 55,000–60,000 kDa cell surface protein. Although M24met cells secrete uPA, they are unable to efficiently utilize this enzyme for invasion, unless it is bound to its receptor. This contention is based on the finding that an antibody against uPAR (monoclonal antibody 3936) inhibited invasion of M24met cells through a reconstituted basement membrane (Matrigel) up to 33%, while a reduction of uPA catalytic activity by its plasminogen activator inhibitor-2 resulted in 46% inhibition of invasion. Furthermore, uPAR is involved in signal transduction events in M24met cells, since both uPA and its amino-terminal fragment stimulated the migration of melanoma cells toward Matrigel, resulting in maximal increases of 32 and 72%, respectively. Our results indicate that both uPA and uPAR are involved in melanoma metastasis and that uPAR contributes to at least two important steps in this process, matrix dissolution and migration.

1 Data presented in this publication were obtained by A.S. as part of his doctoral thesis to be submitted to the Faculty of Biology at the University of Hamburg. This is The Scripps Research Institute manuscript 8370-IMM.

2 Recipient of a fellowship from the Studienstiftung des Deutschen Volkes.

3 To whom requests for reprints should be addressed, at Department of Immunology, The Scripps Research Institute, 10666 N. Torrey Pines Road, La Jolla, CA 92037.

Received 12/13/93. Accepted 4/ 5/94.




This article has been cited by other articles:


Home page
Cancer Res.Home page
J.-W. Liu, P. Sun, Q. Yan, A. S. Paller, P. Gerami, N. Ho, N. Vashi, I. C. Le Poole, and X.-q. Wang
De-N-acetyl GM3 Promotes Melanoma Cell Migration and Invasion through Urokinase Plasminogen Activator Receptor Signaling-Dependent MMP-2 Activation
Cancer Res., November 15, 2009; 69(22): 8662 - 8669.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
H.-J. Kwak, M.-J. Park, H. Cho, C.-M. Park, S.-I. Moon, H.-C. Lee, I.-C. Park, M.-S. Kim, C. H. Rhee, and S.-I. Hong
Transforming Growth Factor-{beta}1 Induces Tissue Inhibitor of Metalloproteinase-1 Expression via Activation of Extracellular Signal-Regulated Kinase and Sp1 in Human Fibrosarcoma Cells
Mol. Cancer Res., March 1, 2006; 4(3): 209 - 220.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. S. Gondi, S. S. Lakka, N. Yanamandra, W. C. Olivero, D. H. Dinh, M. Gujrati, C. H. Tung, R. Weissleder, and J. S. Rao
Adenovirus-Mediated Expression of Antisense Urokinase Plasminogen Activator Receptor and Antisense Cathepsin B Inhibits Tumor Growth, Invasion, and Angiogenesis in Gliomas
Cancer Res., June 15, 2004; 64(12): 4069 - 4077.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. S. Chand, X. Du, D. Ma, H. D. Inzunza, S. Kamei, D. Foster, S. Brodie, and W. Kisiel
The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice
Blood, February 1, 2004; 103(3): 1069 - 1077.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
D. Leake, T. D. Doerr, and G. Scott
Expression of Urokinase-type Plasminogen Activator and Its Receptor in Keloids
Arch Otolaryngol Head Neck Surg, December 1, 2003; 129(12): 1334 - 1338.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. S. Lakka, C. S. Gondi, N. Yanamandra, D. H. Dinh, W. C. Olivero, M. Gujrati, and J. S. Rao
Synergistic Down-Regulation of Urokinase Plasminogen Activator Receptor and Matrix Metalloproteinase-9 in SNB19 Glioblastoma Cells Efficiently Inhibits Glioma Cell Invasion, Angiogenesis, and Tumor Growth
Cancer Res., May 15, 2003; 63(10): 2454 - 2461.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Koolwijk, N. Sidenius, E. Peters, C. F. M. Sier, R. Hanemaaijer, F. Blasi, and V. W. M. van Hinsbergh
Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices
Blood, May 15, 2001; 97(10): 3123 - 3131.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. Ferland, M. Guilbert, F. Davoine, N. Flamand, J. Chakir, and M. Laviolette
Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system
J. Leukoc. Biol., May 1, 2001; 69(5): 772 - 778.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
C. Foca, E.K. Moses, M.A. Quinn, and G.E. Rice
Differential expression of the {alpha}2-macroglobulin receptor and the receptor associated protein in normal human endometrium and endometrial carcinoma
Mol. Hum. Reprod., October 1, 2000; 6(10): 921 - 927.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. HAJ-YEHIA, T. NASSAR, B. S. SACHAIS, A. KUO, K. BDEIR, A. B. AL-MEHDI, A. MAZAR, D. B. CINES, and A. A.-R. HIGAZI
Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo
FASEB J, July 1, 2000; 14(10): 1411 - 1422.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
H. Shiomi, Y. Eguchi, T. Tani, M. Kodama, and T. Hattori
Cellular Distribution and Clinical Value of Urokinase-Type Plasminogen Activator, Its Receptor, and Plasminogen Activator Inhibitor-2 in Esophageal Squamous Cell Carcinoma
Am. J. Pathol., February 1, 2000; 156(2): 567 - 575.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. Webb, D. Nguyen, and S. Gonias
Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion
J. Cell Sci., January 1, 2000; 113(1): 123 - 134.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
U. Benbow, M. P. Schoenermark, T. I. Mitchell, J. L. Rutter, K.-i. Shimokawa, H. Nagase, and C. E. Brinckerhoff
A Novel Host/Tumor Cell Interaction Activates Matrix Metalloproteinase 1 and Mediates Invasion through Type I Collagen
J. Biol. Chem., September 3, 1999; 274(36): 25371 - 25378.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. H. Xing and S. A. Rabbani
Regulation of Urokinase Production by Androgens in Human Prostate Cancer Cells: Effect on Tumor Growth and Metastases in Vivo
Endocrinology, September 1, 1999; 140(9): 4056 - 4064.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Guilbert, C. Ferland, M. Bossé, N. Flamand, S. Lavigne, and M. Laviolette
5-Oxo-6,8,11,14-Eicosatetraenoic Acid Induces Important Eosinophil Transmigration through Basement Membrane Components . Comparison of Normal and Asthmatic Eosinophils
Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 97 - 104.
[Abstract] [Full Text]


Home page
ThoraxHome page
G Cox, W P Steward, and K J O'Byrne
The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer
Thorax, February 1, 1999; 54(2): 169 - 179.
[Full Text]


Home page
J. Cell Sci.Home page
N Nayeem, S Silletti, X Yang, V. Lemmon, R. Reisfeld, W. Stallcup, and A. Montgomery
A potential role for the plasmin(ogen) system in the posttranslational cleavage of the neural cell adhesion molecule L1
J. Cell Sci., January 12, 1999; 112(24): 4739 - 4749.
[Abstract] [PDF]


Home page
GutHome page
S Suzuki, Y Hayashi, Y Wang, T Nakamura, Y Morita, K Kawasaki, K Ohta, N Aoyama, S R Kim, H Itoh, et al.
Urokinase type plasminogen activator receptor expression in colorectal neoplasms
Gut, December 1, 1998; 43(6): 798 - 805.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
C. M. Ferrier, W. L. van Geloof, H. H. de Witte, M. D. Kramer, D. J. Ruiter, and G. N.P. van Muijen
Epitopes of Components of the Plasminogen Activation System are Re-exposed in Formalin-fixed Paraffin Sections by Different Retrieval Techniques
J. Histochem. Cytochem., April 1, 1998; 46(4): 469 - 476.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J.-M. Herbert, I. Lamarche, and P. Carmeliet
Urokinase and Tissue-type Plasminogen Activator Are Required for the Mitogenic and Chemotactic Effects of Bovine Fibroblast Growth Factor and Platelet-derived Growth Factor-BB for Vascular Smooth Muscle Cells
J. Biol. Chem., September 19, 1997; 272(38): 23585 - 23591.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
W. Yu, J. Kim, and L. Ossowski
Reduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy
J. Cell Biol., May 5, 1997; 137(3): 767 - 777.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S Bonavaud, C Charriere-Bertrand, C Rey, M. Leibovitch, N Pedersen, E Frisdal, E Planus, F Blasi, R Gherardi, and G Barlovatz-Meimon
Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion
J. Cell Sci., January 5, 1997; 110(9): 1083 - 1089.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
M. Yebra, G. C.N. Parry, S. Stromblad, N. Mackman, S. Rosenberg, B. M. Mueller, and D. A. Cheresh
Requirement of Receptor-bound Urokinase-type Plasminogen Activator for Integrin alpha vbeta 5-directed Cell Migration
J. Biol. Chem., November 15, 1996; 271(46): 29393 - 29399.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. S. Okada, S. R. Grobmyer, and E. S. Barnathan
Contrasting Effects of Plasminogen Activators, Urokinase Receptor, and LDL Receptor–Related Protein on Smooth Muscle Cell Migration and Invasion
Arterioscler Thromb Vasc Biol, October 1, 1996; 16(10): 1269 - 1276.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Ghosh, R. Brown, J. C. R. Jones, S. M. Ellerbroek, and M. S. Stack
Urinary-type Plasminogen Activator (uPA) Expression and uPA Receptor Localization Are Regulated by alpha 3beta 1 Integrin in Oral Keratinocytes
J. Biol. Chem., July 28, 2000; 275(31): 23869 - 23876.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Pucci, G. Fibbi, L. Magnelli, and M. Del Rosso
Regulation of Urokinase/Urokinase Receptor Interaction by Heparin-like Glycosaminoglycans
J. Biol. Chem., February 9, 2001; 276(7): 4756 - 4765.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.